MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands

Laura Plant1, Hong Wan, Ann-Beth Jonsson

  • 1Department of Medical Biochemistry and Microbiology, Biomedical Centrum, Uppsala University, 751 23 Uppsala, Sweden. Laura.Plant@smi.ki.se

Insights

Meningococcal sepsis is driven by lipooligosaccharide (LOS) and other ligands. Non-LOS ligands signal through the MyD88-dependent pathway, crucial for innate immunity against bacterial infections.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Toll-like receptors (TLRs) and myeloid differentiation factor 88 (MyD88) are key components of innate immunity against microbial infections.
  • Meningococcal ligands, including lipooligosaccharide (LOS), activate TLRs, potentially leading to severe sepsis.

Purpose of the Study:

  • To investigate the role of MyD88 in host defense against meningococcal infections.
  • To differentiate the signaling pathways of LOS and non-LOS meningococcal ligands.

Main Methods:

  • Utilized an isogenic LOS-deficient mutant of serogroup C Neisseria meningitidis (strain FAM20) in wild-type and MyD88-/- C57BL/6 mice.
  • Monitored survival, serum cytokine and C5a levels, neutrophil counts, and bacteremia post-infection.

Main Results:

  • LOS-deficient meningococci caused fatal disease in wild-type mice but not in MyD88-/- mice, indicating MyD88 dependence for non-LOS ligand effects.
  • Fatality in wild-type mice correlated with elevated pro-inflammatory cytokines, C5a, neutrophils, and bacteremia.
  • Wild-type mice infected with the parent strain had 100% fatality, while MyD88-/- mice had 50% fatality, suggesting both LOS and non-LOS ligands contribute to sepsis.

Conclusions:

  • Both LOS and non-LOS meningococcal ligands contribute to sepsis in a mouse model.
  • Non-LOS ligands exclusively signal through the MyD88-dependent pathway.
  • Meningococcal LOS utilizes both MyD88-dependent and -independent pathways in sepsis pathogenesis.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...